AF
APLT

Amalgamated Financial’s Applied Therapeutics APLT Stock Holding History

Amalgamated Financial’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Buy
+2,828
New +$7.58K ﹤0.01% 2950

Other funds holding APLT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's APLT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Applied Therapeutics (APLT) in Q1 2022: 2,828 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2950 among its holdings.

71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

  • Amalgamated Financial held 2,828 shares of Applied Therapeutics worth $6K as of Q1 2022.
  • Applied Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Applied Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2950 holding.
  • 71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.